Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Pediatric OCD Talus RCT Feasibility

16 novembre 2026 aggiornato da: Magdalena Tarchala, Children's Hospital of Eastern Ontario

Feasibility of a Randomized Trial Comparing Viable Cartilage Allograft and Arthroscopic Drilling for Pediatric Talar Osteochondritis Dissecans

Osteochondritis dissecans (OCD) of the talus is a condition affecting the bone and cartilage of the ankle joint. It can cause pain, swelling, stiffness, and difficulty participating in sports and daily activities. Children and adolescents with persistent symptoms or unstable lesions may require surgery when nonsurgical treatments are unsuccessful.

Two surgical approaches used to treat this condition are arthroscopic drilling and chondroplasty, which aim to stimulate healing of the affected bone and cartilage, and viable cartilage allograft implantation, which uses donated cartilage material to repair the damaged area. There is limited evidence comparing these treatments in children and adolescents, and it is not known whether one approach provides better outcomes.

This pilot randomized controlled trial aims to assess the feasibility of conducting a larger study comparing these two surgical treatments in pediatric patients with talar OCD. Approximately 20 participants requiring surgery will be recruited at the Children's Hospital of Eastern Ontario (CHEO) and randomly assigned to receive either viable cartilage allograft implantation (CartiMax®) or arthroscopic drilling and chondroplasty.

The primary objective is to assess the feasibility of recruitment, acceptance of randomization, participant retention, completion of imaging and questionnaires, and adherence to the study procedures. Secondary objectives include exploring differences in ankle pain, function, healing on magnetic resonance imaging (MRI), complications, and the need for additional surgery.

Participants will undergo postoperative rehabilitation according to standard clinical care and will be followed for up to 24 months after surgery.

The findings will help determine whether a larger multicentre randomized trial is feasible and provide preliminary information about healing and recovery following each surgical treatment. This pilot study is not designed to determine which treatment is more effective.

Panoramica dello studio

Descrizione dettagliata

Osteochondritis dissecans (OCD) of the talus is a condition that affects the bone and cartilage in the ankle joint. It can cause pain, swelling, stiffness, and difficulty participating in sports and everyday activities. Some children and adolescents with this condition require surgery when treatments such as rest, activity restrictions, and immobilization have not improved their symptoms.

Two surgical approaches are available to treat this condition. One involves drilling small holes into the affected bone and smoothing damaged cartilage to encourage healing. The other involves placing donated cartilage material into the damaged area to support cartilage repair. It is not yet known whether one approach leads to better healing and recovery in children and adolescents.

The main purpose of this pilot study is to determine whether it is feasible to conduct a larger study comparing these two surgical treatments. Researchers will assess whether enough patients can be recruited, whether families are willing to accept random assignment to either treatment, and whether participants can complete the required follow-up visits, imaging, and questionnaires.

The study will include approximately 20 children and adolescents who require surgery for osteochondritis dissecans of the talus at the Children's Hospital of Eastern Ontario (CHEO) in Ottawa, Canada. Participants will be randomly assigned, like flipping a coin, to receive one of two surgical treatments:

  • **Viable cartilage allograft:** Surgery to prepare the damaged area and place donated cartilage material (CartiMax®) into the defect.
  • **Arthroscopic drilling and chondroplasty:** Surgery using a small camera and instruments to smooth damaged cartilage and drill into the underlying bone to encourage healing.

All participants will receive the same standard postoperative rehabilitation approach. Follow-up assessments will take place approximately 2 weeks, 6 weeks, 3 months, 6 months, 12 months, and 24 months after surgery. Researchers will assess ankle pain, function, healing on imaging, return to sports, complications, and whether additional surgery is needed.

The researchers expect this pilot study to help determine whether a larger randomized trial can be successfully conducted. The study will also provide early information about healing and recovery after each treatment. Because this is a small pilot study, it is not designed to determine which surgical treatment is better.

Tipo di studio

Interventistico

Iscrizione (Stimato)

20

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

  • Nome: Holly Livock Research Manager, MSc.
  • Numero di telefono: 4120 6137377600
  • Email: hlivock@cheo.on.ca

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 5 anni a 18 anni (Bambino, Adulto)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Patients aged ≤ 5 years and ≥ 18 years
  • Patients seen at the CHEO Orthopaedic Sports Medicine Clinic with symptomatic talar OCD requiring surgery
  • Patients that have an unstable lesion on MRI
  • Must be able to complete patient-reported outcome measures in English or French
  • Are willing to be randomized between the two unblinded surgical approaches.
  • Participants must have had failure of non-operative treatment including rest, activity restriction, and six weeks of immobilization.

Exclusion Criteria:

  • Unwillingness to attend follow-up appointments or complete research activities.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Viable Cartilage Allograft (CartiMax)

Participants undergo arthroscopic lesion preparation followed by implantation of CartiMax viable cartilage allograft into the damaged area of the talus. Standard postoperative rehabilitation is provided.

Participants undergo arthroscopic preparation of the talar osteochondral lesion followed by implantation of CartiMax viable cartilage allograft, consisting of viable cartilage fibers and cartilage allograft matrix. The graft is placed into the cartilage defect to support repair. Participants follow the standard postoperative rehabilitation protocol.

Comparatore attivo: Arthroscopic Drilling and Chondroplasty

Participants undergo arthroscopic drilling and chondroplasty to remove or smooth unstable cartilage and stimulate healing of the underlying bone. Standard postoperative rehabilitation is provided.

Participants undergo arthroscopic drilling and chondroplasty of the talar osteochondral lesion. Unstable cartilage is removed or smoothed, and small channels are drilled into the affected bone to stimulate healing. Participants follow the standard postoperative rehabilitation protocol.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Recruitment Rate
Lasso di tempo: 24 months

Number of participants enrolled per year during the recruitment period. Recruitment feasibility will be assessed against a target of at least 10 participants enrolled per year.

24 months

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Questionnaire Completion Rate at 6 Months
Lasso di tempo: 6 months after surgery

Proportion of randomized participants who complete the required 6-month postoperative pain and ankle function assessments, including the Visual Analogue Scale (VAS) and American Orthopaedic Foot and Ankle Society (AOFAS) ankle-hindfoot score. The target questionnaire completion rate is at least 80%.

6 months after surgery
MRI Completion Rate at 6 Months
Lasso di tempo: 6 months after surgery

Proportion of randomized participants who complete the scheduled 6-month postoperative magnetic resonance imaging (MRI) assessment. The target MRI completion rate is at least 80%.

6 months after surgery
Participant Retention Rate at 6 Months
Lasso di tempo: 24 months

Proportion of randomized participants who remain in the study and complete the 6-month postoperative follow-up assessment. The target retention rate is at least 70%.

24 months
Randomization Acceptance Rate
Lasso di tempo: 24 months

Proportion of eligible patients approached for participation who consent to random assignment to either surgical treatment. The target randomization acceptance rate is at least 80%.

24 months
Adherence to Randomized Treatment Allocation
Lasso di tempo: At the time of surgery (assessed up to 1 hour)

Proportion of randomized participants who undergo their assigned surgical intervention, either viable cartilage allograft implantation or arthroscopic drilling and chondroplasty. Crossovers and deviations from assigned treatment will be documented.

At the time of surgery (assessed up to 1 hour)

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Pubblicazioni generali

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

1 gennaio 2027

Completamento primario (Stimato)

1 gennaio 2029

Completamento dello studio (Stimato)

1 gennaio 2030

Date di iscrizione allo studio

Primo inviato

10 novembre 2026

Primo inviato che soddisfa i criteri di controllo qualità

16 novembre 2026

Primo Inserito (Effettivo)

18 novembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

18 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

16 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • 26/10E

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi